| Outcome Measures: |
Primary: Change in glycated haemoglobin (HbA1c), Measured in percentage point., From baseline (week 0) to end of study visit(week 26 [-4 to +8 weeks]) | Secondary: Participants reaching individual HbA1c target set by physician, Measured as number of participants (yes/no)., end of study visit (week 26 [-4 to +8 weeks])|Participants reaching physician set individual fasting blood glucose (FBG) target, Measured as number of participants (yes/no)., From baseline (week 0) to end of study visit(week 26 [-4 to +8 weeks])|Time to physician set individual FBG target from first reported FBG, Measured in weeks., From baseline (week 0) to end of study visit(week 26 [-4 to +8 weeks])|Participants achieving target level FBG according to clinical guidance, Measured as number of participants (yes/no)., From baseline (week 0) to end of study visit(week 26 [-4 to +8 weeks])|Change in laboratory measured FPG, Measured in milligrams per deciliter (mg/dL)., From baseline (week 0) to end of study visit(week 26 [-4 to +8 weeks])
|
| Locations: |
Dr. Sulaiman Al Habib- Al Qassim, Buraidah, Al Qassim, 51431, Saudi Arabia|Sulaiman Al Habib- Al Khobar, Al Khobar, 34423, Saudi Arabia|King Fahad Hospital of the University, Alkhobar, 34445, Saudi Arabia|Almoosa Specialist Hospital, Ihsaa, 22141, Saudi Arabia|Saudi airlines Medical Services, Jeddah, 21231, Saudi Arabia|Saudi German Hospital, Jeddah, 23521, Saudi Arabia|My clinic, Jeddah, Saudi Arabia|Saudi German Hospital, Khamis Mushait, 62451, Saudi Arabia|Al Mowasat Khobar, Khobar, 34234, Saudi Arabia|King Fahd Medical City, Riyadh, KSA, Riyadh, 12231, Saudi Arabia|Al Hammadi, Riyadh, 12474, Saudi Arabia|Dr. Sulaiman Al Habib Medical Group- Swedi, Riyadh, 12987, Saudi Arabia
|
